Healthcare | July 11, 2023
Bausch + Lomb acquires Blink eye drops
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
This innovative product eliminates two manufacturing steps and simplifies equipment setup
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
Subscribe To Our Newsletter & Stay Updated
